You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antibody Dependent Cellular Cytotoxicity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and

Not yet recruiting
  • HER2+ Advanced Breast Cancer
  • Other Solid Tumors
  • ADCC-R-Epo-R T-cells + Trastuzumab
  • +2 more
  • (no location specified)
Aug 31, 2023

Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)

Recruiting
  • Locally Advanced Breast Cancer
  • Chemotherapy Effect
  • inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
  • Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 28, 2023

Cutaneous Squamous Cell Carcinoma Trial in Waratah, Melbourne, Nedlands (Imgatuzumab)

Suspended
  • Cutaneous Squamous Cell Carcinoma
  • Waratah, New South Wales, Australia
  • +2 more
May 17, 2022

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Subclass of Donor-specific Antibody asRisk Factor of Antibody

Active, not recruiting
  • Antibody-mediated Rejection
    • Montpellier, Hérault, France
      CHU Lapeyronie
    Jan 18, 2023

    Neuroblastoma Trial in New York (beta-glucan, mAb 3F8, immunohistochemistry staining method)

    Completed
    • Neuroblastoma
    • beta-glucan
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 4, 2022

    Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

    Completed
    • Multiple Myeloma
    • +7 more
    • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 2, 2022

    Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum

    Not yet recruiting
    • Neuromyelitis Optica Spectrum Disorders
    • (no location specified)
    Sep 29, 2023

    Castration Resistant Prostate Cancer Trial run by the National Cancer Institute (NCI) (Bintrafusp alfa, N-803, BN-Brachyury)

    Not yet recruiting
    • Castration Resistant Prostate Cancer
    • Bintrafusp alfa
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)

    Recruiting
    • Rheumatoid Arthritis
    • +8 more
    • COVID-19 vaccine
    • Montréal, Quebec, Canada
    • +1 more
    Jan 13, 2023

    COVID-19 Transmission and Morbidity in Malawi

    Recruiting
    • SARS CoV 2 Infection
    • SARS CoV 2 Vaccination
      • Boston, Massachusetts
      • +1 more
      Aug 6, 2023

      HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)

      Completed
      • HIV Infections
      • MN rgp120/HIV-1 and A244 rgp120/HIV-1
      • +2 more
      • Baltimore, Maryland
      • +3 more
      Oct 28, 2021

      Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

      Terminated
      • Neuroblastoma
      • antibody ch14.18
      • +4 more
      • Cologne, Germany
        University of Cologne
      Nov 3, 2022

      Neuroblastoma Trial in Wien, Greifswald (dinutuximab beta)

      Active, not recruiting
      • Neuroblastoma
      • dinutuximab beta
      • Wien, Austria
      • +1 more
      Oct 1, 2021

      HIV Infection Trial in New York (Colonoscopy)

      Not yet recruiting
      • HIV Infection
      • Colonoscopy
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Dec 7, 2022

      Urinary Bladder Tumors Trial in München (Catumaxomab)

      Recruiting
      • Urinary Bladder Neoplasms
      • München, Germany
        Urologie Planegg
      Apr 4, 2022

      SARS-CoV-2-specific Immunity in Individuals Who Have Recovered

      Active, not recruiting
      • SARS-CoV-2
      • COVID-19
      • Sample collection
      • Birmingham, Alabama
      • +52 more
      Sep 3, 2021

      Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive

      Active, not recruiting
      • Aggressive B-Cell Non-Hodgkin Lymphoma
      • fractionated first dose rituximab
      • Geneva, Switzerland
        University Hospital Geneva
      Apr 21, 2023

      HIV Trial in Johannesburg (CH505TF gp120, GLA-SE adjuvant, Placebo)

      Recruiting
      • HIV Infections
      • CH505TF gp120
      • +2 more
      • Johannesburg, Gauteng, South Africa
        Perinatal HIV Research Unit (PHRU), Soweto CRS
      Apr 29, 2022

      Recurrent Colon Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma Trial

      Completed
      • Recurrent Colon Carcinoma
      • +41 more
      • Cetuximab
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Mar 12, 2020

      HIV/AIDS Trial in Bangkok (N-803)

      Recruiting
      • HIV/AIDS
      • Bangkok, Thailand
        Thai Red Cross AIDS Research Centre
      Oct 4, 2021

      Tumor, Gynecologic Trial in Belgium, France, United Kingdom (GM102, GM102 escalating doses)

      Completed
      • Neoplasm, Gynecologic
      • GM102
      • GM102 escalating doses
      • Brussels, Belgium
      • +11 more
      Mar 27, 2022

      Malaria Trial in Bagamoyo (SumayaVac-1(SUM-101), Verorab, CHMI)

      Not yet recruiting
      • Malaria
      • SumayaVac-1(SUM-101)
      • +2 more
      • Bagamoyo, Tanzania
        Ifakara Health Institute
      Dec 1, 2022

      Colorectal Cancer Trial in Belgium, Czechia (GM102, Trifluridine/Tipiracil, GM102 expansion)

      Completed
      • Colorectal Cancer
      • Brussels, Belgium
      • +4 more
      Apr 11, 2022

      Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

      Recruiting
      • Metastatic Prostate Cancer
      • +4 more
      • M7824
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023